BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 10436095)

  • 21. Post rtPA CT brain may not be mandatory in all stroke patients when resources are limited.
    Dharmasaroja PA; Muengtaweepongsa S; Dharmasaroja P
    Clin Neurol Neurosurg; 2013 Mar; 115(3):285-8. PubMed ID: 22749008
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hyperdense middle cerebral artery sign: can it be used to select intra-arterial versus intravenous thrombolysis in acute ischemic stroke?
    Agarwal P; Kumar S; Hariharan S; Eshkar N; Verro P; Cohen B; Sen S
    Cerebrovasc Dis; 2004; 17(2-3):182-90. PubMed ID: 14707420
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Review, historical context, and clarifications of the NINDS rt-PA stroke trials exclusion criteria: Part 1: rapidly improving stroke symptoms.
    ; Levine SR; Khatri P; Broderick JP; Grotta JC; Kasner SE; Kim D; Meyer BC; Panagos P; Romano J; Scott P;
    Stroke; 2013 Sep; 44(9):2500-5. PubMed ID: 23847249
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predicting major neurological improvement with intravenous recombinant tissue plasminogen activator treatment of stroke.
    Brown DL; Johnston KC; Wagner DP; Haley EC
    Stroke; 2004 Jan; 35(1):147-50. PubMed ID: 14657446
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
    Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
    Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Wake-up stroke within 3 hours of symptom awareness: imaging and clinical features compared to standard recombinant tissue plasminogen activator treated stroke.
    Roveri L; La Gioia S; Ghidinelli C; Anzalone N; De Filippis C; Comi G
    J Stroke Cerebrovasc Dis; 2013 Aug; 22(6):703-8. PubMed ID: 22133742
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The URICO-ICTUS study, a phase 3 study of combined treatment with uric acid and rtPA administered intravenously in acute ischaemic stroke patients within the first 4.5 h of onset of symptoms.
    Amaro S; Cánovas D; Castellanos M; Gállego J; Martí-Fèbregas J; Segura T; Chamorro A
    Int J Stroke; 2010 Aug; 5(4):325-8. PubMed ID: 20636718
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical deterioration following improvement in the NINDS rt-PA Stroke Trial.
    Grotta JC; Welch KM; Fagan SC; Lu M; Frankel MR; Brott T; Levine SR; Lyden PD
    Stroke; 2001 Mar; 32(3):661-8. PubMed ID: 11239184
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ASPECT scoring to estimate >1/3 middle cerebral artery territory infarction.
    Demaerschalk BM; Silver B; Wong E; Merino JG; Tamayo A; Hachinski V
    Can J Neurol Sci; 2006 May; 33(2):200-4. PubMed ID: 16736730
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Prerequisites, indications and contraindications of IV-lysis of ischemic stroke with rt-PA].
    Marx P; Hartmann A; Leistner S; Nohr R; Koennecke HC
    Fortschr Neurol Psychiatr; 2001 Aug; 69(8):346-52. PubMed ID: 11584683
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Perfusion computed tomography-guided intravenous thrombolysis for acute ischemic stroke beyond 4.5 hours: a case-control study.
    García-Bermejo P; Calleja AI; Pérez-Fernández S; Cortijo E; del Monte JM; García-Porrero M; Fe Muñoz M; Fernández-Herranz R; Arenillas JF
    Cerebrovasc Dis; 2012; 34(1):31-7. PubMed ID: 22759450
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Symptomatic intracranial hemorrhage following intravenous thrombolysis for acute ischemic stroke: a critical review of case definitions.
    Seet RC; Rabinstein AA
    Cerebrovasc Dis; 2012; 34(2):106-14. PubMed ID: 22868870
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Telemedical Brain Computed Tomography Misinterpretation by Stroke Neurologists Is Not Associated with Thrombolysis-Related Intracranial Hemorrhage.
    Zerna C; von Kummer R; Gerber J; Engellandt K; Abramyuk A; Wojciechowski C; Barlinn K; Kepplinger J; Pallesen LP; Siepmann T; Dzialowski I; Reichmann H; Puetz V; Bodechtel U
    J Stroke Cerebrovasc Dis; 2015 Jul; 24(7):1520-6. PubMed ID: 25873473
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early ischemic change on CT versus diffusion-weighted imaging for patients with stroke receiving intravenous recombinant tissue-type plasminogen activator therapy: stroke acute management with urgent risk-factor assessment and improvement (SAMURAI) rt-PA registry.
    Nezu T; Koga M; Nakagawara J; Shiokawa Y; Yamagami H; Furui E; Kimura K; Hasegawa Y; Okada Y; Okuda S; Kario K; Naganuma M; Maeda K; Minematsu K; Toyoda K
    Stroke; 2011 Aug; 42(8):2196-200. PubMed ID: 21719764
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hemostatic activation and outcome after recombinant tissue plasminogen activator therapy for acute ischemic stroke.
    Tanne D; Macko RF; Lin Y; Tilley BC; Levine SR;
    Stroke; 2006 Jul; 37(7):1798-804. PubMed ID: 16763191
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke: initial Israeli experience.
    Schwammenthal Y; Drescher MJ; Merzeliak O; Tsabari R; Bruk B; Feibel M; Hoffman C; Bakon M; Rotstein Z; Chapman J; Tanne D
    Isr Med Assoc J; 2004 Feb; 6(2):70-4. PubMed ID: 14986460
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Monitoring intravenous recombinant tissue plasminogen activator thrombolysis for acute ischemic stroke with diffusion and perfusion MRI.
    Schellinger PD; Jansen O; Fiebach JB; Heiland S; Steiner T; Schwab S; Pohlers O; Ryssel H; Sartor K; Hacke W
    Stroke; 2000 Jun; 31(6):1318-28. PubMed ID: 10835451
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proof of concept study: relating infarct location to stroke disability in the NINDS rt-PA trial.
    Phan TG; Demchuk A; Srikanth V; Silver B; Patel SC; Barber PA; Levine SR; Hill MD
    Cerebrovasc Dis; 2013; 35(6):560-5. PubMed ID: 23838753
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcome of patients with negative CT angiography results for arterial occlusion treated with intravenous thrombolysis.
    Mikulik R; Goldemund D; Reif M; Aulicky P; Krupa P
    Stroke; 2009 Mar; 40(3):868-72. PubMed ID: 19131650
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interrater variability for CT angiography evaluation between neurologists and neuroradiologist in acute stroke patients.
    Bar M; Kral J; Jonszta T; Marcian V; Kuliha M; Mikulik R
    Br J Radiol; 2017 Mar; 90(1071):20160670. PubMed ID: 28118025
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.